Major Shareholder Announcement

Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has increased its holding of B shares in Novozymes to 7.82%, previously reported at 7.71% (an increase of 0.11%).

27. July 2012
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 25,413,977 shares of a nominal value of DKK 50,827,954, equivalent to 7.82% of Novozymes A/S’ share capital and 3.14% of the voting rights. The announcement is a result of Baillie Gifford Overseas Limited, a wholly owned subsidiary of Baillie Gifford & Co, increasing its holding of B shares in Novozymes A/S to a total of 16,327,429 B shares of a nominal value of DKK 32,654,858, equivalent to 5.02% of Novozymes share capital.
 
Contact persons:
Press and media:
Investor relations:
 
René Tronborg (Europe)
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274
 
Paige Donnelly (USA)
Tel. (direct): +1 919 494 3209
Tel. (mobile): +1 919 218 4501
 
Martin Riise
Tel. (direct): +45 4446 0738
Tel. (mobile): +45 3077 0738
 
Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3483
Tel. (mobile):  +1 919 649 2565